Clinical trial
Does Interleukin-1 Receptor Antagonist Improve Outcome Following Aneurysmal Subarachnoid Haemorrhage (aSAH)? A Phase III Trial
NCT03249207 is registered in ClinicalTrials.gov with University of Manchester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Interleukin-1 Receptor Antagonist Improve Outcome Following Aneurysmal Subarachnoid Haemorrhage (aSAH)? A Phase III Trial
- Lead sponsor
- University of Manchester
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- October 11, 2018
- Completion date
- September 30, 2024
- Enrollment
- 612 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.